Clinical Trial Update: Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for DCVax-L in newly diagnosed glioblastoma multiforme is reported with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Neoplasm
• Brain Tumor
• Glioblastoma
• Glioblastoma Multiforme
• Glioma
• Grade Iv Astrocytoma

Drugs mentioned

• DCVax-L

Snippet

Sponsor: Northwest Biotherapeutics | Conditions: Glioblastoma Multiforme, Glioblastoma | Phase 3 | Status: UNKNOWN